Jiangsu Nhwa Pharmaceutical Co., LTD (SHE:002262)

China · Delayed Price · Currency is CNY

23.70

-0.05 (-0.21%)

Feb 13, 2026, 3:04 PM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Commercial	792.83M	-	-	-	-
Manufacturing	4.87B	-	-	-	-
Others	126.38M	-	-	-	-
Intersegment Offset	-89.38M	-	-	-	-
Total	5.70B	-	-	-	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2023	FY 2022	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
China	5.61B	4.97B	4.24B	3.90B	3.32B
China Growth	13.04%	17.18%	8.78%	17.33%	-19.28%
Foreign	23.29M	8.87M	16.42M	22.80M	23.42M
Foreign Growth	162.53%	-46.00%	-27.97%	-2.65%	26.16%
Unallocated	59.61M	65.63M	43.49M	16.53M	16.99M
Unallocated Growth	-9.19%	50.93%	163.08%	-2.73%	2.26%
Total	5.70B	5.04B	4.30B	3.94B	3.36B
Total Growth	13.01%	17.28%	9.22%	17.09%	-18.99%

Source: S&P Global Market Intelligence.